celecoxib and mobic

celecoxib has been researched along with mobic in 68 studies

Research

Studies (68)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (7.35)	18.2507
2000's	33 (48.53)	29.6817
2010's	22 (32.35)	24.3611
2020's	8 (11.76)	2.80

Authors

Authors	Studies
Brideau, C; Chan, CC; Charleson, S; Cromlish, W; Ethier, D; Evans, JF; Ford-Hutchinson, AW; Gauthier, JY; Gordon, R; Gresser, M; Guay, J; Kargman, S; Kennedy, B; Leblanc, Y; Léger, S; Mancini, J; O'Neill, GP; Ouellet, M; Percival, MD; Perrier, H; Prasit, P; Riendeau, D; Rodger, I; Wang, Z; Zamboni, R	1
Byun, Y; Choi, JK; Choi, YH; Chung, S; Jeong, YS; Kim, JK; Kim, JY; Koh, HJ; Lee, KW; Lim, KM; Moh, JH; Noh, MS; Oh, YI; Park, YH; Shin, SS	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Ekins, S; Williams, AJ; Xu, JJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Abdel-Aziz, AA; Abou-Zeid, LA; Ayyad, RR; El-Azab, AS; El-Sayed, MA; ElTahir, KEH	1
Das, RD; Nivsarkar, M; Panchal, NB; Sagar, SR; Singh, DP; Sudarsanam, V; Vasu, KK	1
Cui, E; Du, L; Du, S; Jiang, X; Li, J; Ma, X; Qian, S; Wang, H	1
Chan, JT; Housholder, GT	1
Houben, JJ; Liem, B	1
Wallace, JL	1
Brater, DC	1
Hawkey, CJ; Jackson, LM	1
Frölich, JC; Stichtenoth, DO	1
Gierse, JK; Isakson, PC; Kiefer, JR; Koboldt, CM; Kurumbail, RG; Moreland, KT; Seibert, K; Walker, MC	1
Mejza, F; Nizankowska, E	1
Swaak, AJ; Theunissen, DJ	1
Friel, AM; Healy, DG; Morrison, JJ; Slattery, MM	1
Beauchamp, BK; Ding, I; Fenton, BM; Okunieff, P; Paoni, SF	1
Bai, JC; Mauriño, E; Meddings, J; Niveloni, S; Pedreira, S; Smecuol, E; Sugai, E; Vazquez, H	1
Akiguchi, I; Kawasaki, T; Miyake, S; Miyamoto, K; Oka, N; Yamamura, T	1
Capriotti, T	1
Hawkey, CJ	1
Breuhahn, K; Dienes, HP; Haugg, AM; Kern, MA; Moll, I; Sahi, D; Schirmacher, P; Schöneweiss, MM; Schubert, D	1
Lane, S; Linley, W; Maskrey, N; McQuade, C; Micklewright, R; Thompson, F	1
Devière, J	1
Harris, S; Hughes, K; Layton, D; Shakir, SA	2
Burke, TA; Goldstein, JL; MacDonald, TM; Morant, SV; Pettitt, D	1
Atik, U; Burak Cimen, MY; Cimen, OB; Erdoğan, C; Eskandari, G; Sahin, G	1
Bhatia, S; Seedher, N	1
Chichorro, JG; Lorenzetti, BB; Zampronio, AR	1
Antonicelli, L; Bilò, MB; Bonadonna, P; Crivellaro, MA; Dama, AR; Schiappoli, M; Senna, G	1
Dahlborg, R; Day, CA; Jacob, RF; Mason, RP; Walter, MF; Weng, Y	1
Bishop-Bailey, D; Mitchell, JA; Vojnovic, I; Warner, TD	1
Hsiao, FY; Huang, WF; Shih, YT; Tsai, YW; Wen, YW	1
Chen, SH; Hsieh, YH; Lin, SJ	1
Huang, MH; Li, X; Ouyang, Q; Tang, CW; Wang, CH	1
Aghazadeh-Habashi, A; Harirforoosh, S; Jamali, F	1
Hilário, MO; Len, CA; Terreri, MT	1
Becker, TL; Gambero, A; Maróstica, M; Pedrazzoli, J	1
Berg, Jv; Kuipers, GK; Lafleur, MV; Slotman, BJ; Sminia, P; Stoter, TR; Wedekind, LE	1
Huang, M; Liu, R; Ouyang, Q; Tang, C; Wang, C	1
Martínez-Cócera, C; Reig Rincón de Arellano, I; Rodríguez-Alvarez, M; Vázquez-Cortés, S; Vázquez-Fuertes, L	1
Kang, P; Li, J; Liu, G; Liu, W; Luo, R; Ma, X; Pei, F; Shen, B; Xie, Q; Zhou, Z	1
Addicks, K; Arnhold, S; Müller, M; Raabe, O; Wenisch, S	1
Knotek, M; Ljubanovic, D; Mihovilovic, K	1
Kalonia, H; Kumar, A	1
Endo, S; Esaki, M; Kobayashi, H; Kochi, S; Maehata, Y; Matsumoto, T; Morishita, T; Shikata, K	1
Beshay, JE; Levy, M; Madden, CJ; Rickert, KL; Sarode, R; Scott, WW	1
Baek, JH; Ha, YC; Ko, YB; Lee, HJ; Park, KJ; Park, SM	1
Barozzi, N; Peeters, GM; Tett, SE	1
Matteson, EL; Thongprayoon, C; Ungprasert, P	1
Aghadavoudi, O; Ramezani, A; Saryazdi, HH; Shafa, A	1
Anderson, B; Cooper, TE; Eccleston, C; Fisher, E; Wilkinson, NM	1
Wang, J	1
Davydkin, IL; Zolotovskaia, IA	1
Hamada, S; Ikuta, K; Ishiguro, N; Koike, H; Nishida, Y; Ota, T; Sakai, T	1
Antonissen, G; Croubels, S; De Backer, P; De Baere, S; Devreese, M; Dhondt, L; Gehring, R; Goessens, T; Haesendonck, R	1
Aghazadeh-Habashi, A; Asghar, W; Jamali, F	1
Chang, CC; Chen, YR; Chi, NF; Chiou, HY; Hsieh, FI; Wu, HC	1
Breckenridge, L; Fillingham, YA; Gursay, D; Haffar, A; Lonner, JH	1
Berkowitz, R; Hacker, S; Hu, J; Lee, GC; Rechter, A	1
Pedersen, L; Schmidt, M; Sørensen, HT	1
Antonen, EG; Kruchek, MM; Nikitina, MV	1
Gorenflo, M; Saur, P; van den Anker, JN; van Dyk, M; Welzel, T; Ziesenitz, VC	1
Çakmak, ME	1

Reviews

15 review(s) available for celecoxib and mobic

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Coming: a review of second-generation nonsteroidal anti-inflammatory drugs. The Journal of the Greater Houston Dental Society, 1997, Volume: 68, Issue:8 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Meloxicam; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thiazines; Thiazoles	1997
Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs). The American journal of medicine, 1999, Dec-13, Volume: 107, Issue:6A Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Controlled Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Etodolac; Gene Expression; Humans; Ibuprofen; Indomethacin; Isoenzymes; Meloxicam; Membrane Proteins; Naproxen; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thiazines; Thiazoles	1999
Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. The American journal of medicine, 1999, Dec-13, Volume: 107, Issue:6A Topics: Anti-Inflammatory Agents, Non-Steroidal; Butanones; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Kidney; Lactones; Meloxicam; Membrane Proteins; Nabumetone; Natriuresis; Nephritis, Interstitial; Potassium; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Renal Circulation; Sodium; Sulfonamides; Sulfones; Thiazines; Thiazoles	1999
COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages? Drugs, 2000, Volume: 59, Issue:6 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Etodolac; Humans; Lactones; Meloxicam; Pyrazoles; Sulfonamides; Sulfones; Thiazines; Thiazoles	2000
[Therapy with preferential and specific COX-2 inhibitors]. Der Internist, 2001, Volume: 42, Issue:3 Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Lactones; Meloxicam; Membrane Proteins; Pain; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones; Thiazines; Thiazoles	2001
[Selective cyclooxygenase 2 inhibitors (COX-2)]. Postepy higieny i medycyny doswiadczalnej, 2001, Volume: 55, Issue:2 Topics: Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Inflammation; Isoenzymes; Lactones; Meloxicam; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Protein Isoforms; Pyrazoles; Sulfonamides; Sulfones; Thiazines; Thiazoles	2001
The new NSAIDs: cox-2 inhibitors. Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, 2000, Volume: 9, Issue:6 Topics: Advertising; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Industry; Gastrointestinal Diseases; Humans; Isoenzymes; Lactones; Meloxicam; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Safety; Sulfonamides; Sulfones; Thiazines; Thiazoles	2000
Cyclooxygenase inhibition: between the devil and the deep blue sea. Gut, 2002, Volume: 50 Suppl 3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Gastroscopy; Humans; Isoenzymes; Kidney; Lactones; Meloxicam; Membrane Proteins; Myocardial Infarction; Prostaglandin-Endoperoxide Synthases; Proton Pump Inhibitors; Pyrazoles; Randomized Controlled Trials as Topic; Stomach Ulcer; Sulfonamides; Sulfones; Thiazines; Thiazoles	2002
Review article: NSAIDs, gastroprotection and cyclo-oxygenase-II-selective inhibitors. Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Etodolac; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Isoenzymes; Lactones; Meloxicam; Membrane Proteins; Practice Guidelines as Topic; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones; Thiazines; Thiazoles	2003
Do selective cyclo-oxygenase inhibitors eliminate the adverse events associated with nonsteroidal anti-inflammatory drug therapy? European journal of gastroenterology & hepatology, 2002, Volume: 14 Suppl 1 Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Humans; Lactones; Meloxicam; Neoplasms; Pyrazoles; Sulfonamides; Sulfones; Thiazines; Thiazoles	2002
Nonsteroidal anti-inflammatory drugs: cyclooxygenase 2 inhibitors. Jornal de pediatria, 2006, Volume: 82, Issue:5 Suppl Topics: Adolescent; Aspirin; Celecoxib; Child; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Interactions; Etoricoxib; Fever; Humans; Hypersensitivity, Immediate; Inflammation; Leukotrienes; Meloxicam; Naproxen; Pain; Prostaglandins; Pyrazoles; Pyridines; Sulfonamides; Sulfones; Thiazines; Thiazoles; Treatment Outcome	2006
Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Observational Studies. Stroke, 2016, Volume: 47, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cerebral Hemorrhage; Diclofenac; Humans; Ibuprofen; Incidence; Indomethacin; Lactones; Meloxicam; Naproxen; Observational Studies as Topic; Odds Ratio; Piroxicam; Proportional Hazards Models; Stroke; Sulfones; Thiazines; Thiazoles	2016
Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents. The Cochrane database of systematic reviews, 2017, 08-02, Volume: 8 Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Arthritis, Rheumatoid; Aspirin; Celecoxib; Child; Child, Preschool; Chronic Disease; Chronic Pain; Fenoprofen; Humans; Ibuprofen; Lactones; Meloxicam; Methoxsalen; Naproxen; Randomized Controlled Trials as Topic; Sulfones; Thiazines; Thiazoles	2017
Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years. Paediatric drugs, 2022, Volume: 24, Issue:6 Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Child; Chronic Disease; Diclofenac; Flurbiprofen; Humans; Ibuprofen; Infant; Ketoprofen; Ketorolac; Meloxicam; Naproxen; Niflumic Acid; Pain	2022

Trials

10 trial(s) available for celecoxib and mobic

Article	Year
Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro. Obstetrics and gynecology, 2001, Volume: 98, Issue:4 Topics: Adult; Celecoxib; Cesarean Section; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Humans; Hysterectomy; Isoenzymes; Labor, Obstetric; Meloxicam; Membrane Proteins; Middle Aged; Myometrium; Pregnancy; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thiazines; Thiazoles; Uterine Contraction	2001
In vivo effects of meloxicam, celecoxib, and ibuprofen on free radical metabolism in human erythrocytes. Drug and chemical toxicology, 2003, Volume: 26, Issue:3 Topics: Catalase; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Erythrocytes; Free Radical Scavengers; Glutathione Peroxidase; Humans; Ibuprofen; Isoenzymes; Malondialdehyde; Meloxicam; Membrane Proteins; Middle Aged; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Superoxide Dismutase; Thiazines; Thiazoles	2003
Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. European annals of allergy and clinical immunology, 2004, Volume: 36, Issue:6 Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Cross Reactions; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Hypersensitivity; Female; Forced Expiratory Volume; Hemodynamics; Humans; Isoenzymes; Lactones; Male; Meloxicam; Membrane Proteins; Middle Aged; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Recurrence; Rhinitis, Allergic, Perennial; Single-Blind Method; Sulfonamides; Sulfones; Thiazines; Thiazoles; Urticaria	2004
[Tolerance to celecoxib and meloxicam in patients with intolerance to nonsteroidal anti-inflammatory drugs]. Anales de medicina interna (Madrid, Spain : 1984), 2008, Volume: 25, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Male; Meloxicam; Middle Aged; Pyrazoles; Single-Blind Method; Sulfonamides; Thiazines; Thiazoles	2008
Efficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck disease (KBD) patients. International orthopaedics, 2011, Volume: 35, Issue:9 Topics: Acetaminophen; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Female; Health Status; Humans; Joints; Kashin-Beck Disease; Male; Meloxicam; Middle Aged; Pain; Pain Measurement; Pyrazoles; Sulfonamides; Thiazines; Thiazoles; Treatment Outcome; Young Adult	2011
Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam. Journal of gastroenterology, 2012, Volume: 47, Issue:4 Topics: Adult; Capsule Endoscopes; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Duodenal Ulcer; Female; Humans; Intestinal Mucosa; Intestine, Small; Male; Meloxicam; Middle Aged; Prospective Studies; Pyrazoles; Sulfonamides; Thiazines; Thiazoles; Young Adult	2012
Assessment of common nonsteroidal anti-inflammatory medications by whole blood aggregometry: a clinical evaluation for the perioperative setting. World neurosurgery, 2014, Volume: 82, Issue:5 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Loss, Surgical; Celecoxib; Cyclooxygenase Inhibitors; Female; Healthy Volunteers; Humans; Ibuprofen; Male; Meloxicam; Middle Aged; Naproxen; Perioperative Care; Platelet Aggregation; Pyrazoles; Sulfonamides; Thiazines; Thiazoles; Young Adult	2014
COMPARISON OF PRE-EMPTIVE EFFECT OF MELOXICAM AND CELECOXCIB ON POST-OPERATIVE ANALGESIA: A DOUBLE-BLIND, RANDOMIZED CLINICAL TRIAL. Middle East journal of anaesthesiology, 2015, Volume: 23, Issue:3 Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; Male; Meloxicam; Middle Aged; Pain, Postoperative; Severity of Illness Index; Thiazines; Thiazoles; Time Factors; Young Adult	2015
Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial. The Journal of international medical research, 2018, Volume: 46, Issue:1 Topics: Adalimumab; Aged; Antirheumatic Agents; Celecoxib; Diclofenac; Female; Humans; Hyaluronic Acid; Ibuprofen; Injections, Intra-Articular; Male; Meloxicam; Middle Aged; Osteoarthritis, Knee; Pain; Pain Measurement; Patient Safety; Pilot Projects; Severity of Illness Index; Thiazines; Thiazoles; Treatment Outcome	2018
HTX-011 in Combination with Multimodal Analgesic Regimen Minimized Severe Pain and Opioid Use after Total Knee Arthroplasty in an Open-Label Study. The journal of knee surgery, 2023, Volume: 36, Issue:9 Topics: Acetaminophen; Analgesics; Analgesics, Opioid; Anesthetics, Local; Arthroplasty, Replacement, Knee; Bupivacaine; Celecoxib; Humans; Meloxicam; Opioid-Related Disorders; Pain, Postoperative	2023

Other Studies

43 other study(ies) available for celecoxib and mobic

Article	Year
The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor. Bioorganic & medicinal chemistry letters, 1999, Jul-05, Volume: 9, Issue:13 Topics: Administration, Oral; Animals; Biological Availability; CHO Cells; Cricetinae; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Humans; Indomethacin; Inhibitory Concentration 50; Isoenzymes; Lactones; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Sulfones	1999
In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives. Journal of medicinal chemistry, 2004, Feb-12, Volume: 47, Issue:4 Topics: Adult; Animals; Arthritis, Experimental; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Edema; Furans; Humans; In Vitro Techniques; Isoenzymes; Macrophages, Peritoneal; Male; Membrane Proteins; Mice; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Structure-Activity Relationship	2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones. European journal of medicinal chemistry, 2016, Oct-04, Volume: 121 Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry Techniques, Synthetic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Mice; Molecular Docking Simulation; Protein Conformation; Quinazolinones	2016
Investigations on substituted (2-aminothiazol-5-yl)(imidazo[1,2-a]pyridin-3-yl)methanones for the treatment of Alzheimer's disease. Bioorganic & medicinal chemistry, 2021, 04-15, Volume: 36 Topics: Aluminum Chloride; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Edema; Female; Formaldehyde; Imidazoles; Inflammation; Male; Molecular Structure; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship	2021
Design and synthesis of novel indole and indazole-piperazine pyrimidine derivatives with anti-inflammatory and neuroprotective activities for ischemic stroke treatment. European journal of medicinal chemistry, 2022, Nov-05, Volume: 241 Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Cyclooxygenase 2; Disease Models, Animal; Indazoles; Indoles; Ischemic Stroke; Lipopolysaccharides; Mice; Microglia; Neuroprotection; Neuroprotective Agents; Piperazine; Pyrimidines; Rats; Stroke; Tumor Necrosis Factor-alpha	2022
[Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs]. Nederlands tijdschrift voor geneeskunde, 1999, Nov-13, Volume: 143, Issue:46 Topics: Anti-Inflammatory Agents, Non-Steroidal; Butanones; Celecoxib; Clinical Trials as Topic; Confounding Factors, Epidemiologic; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Humans; Lactones; Meloxicam; Nabumetone; Pyrazoles; Stomach Diseases; Sulfonamides; Sulfones; Thiazines; Thiazoles	1999
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors. The Biochemical journal, 2001, Aug-01, Volume: 357, Issue:Pt 3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding, Competitive; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Isoxazoles; Kinetics; Meloxicam; Mice; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sheep; Sulfonamides; Thiazines; Thiazoles	2001
[Safety of specific cyclo-oxygenase 2 inhibitors]. Nederlands tijdschrift voor geneeskunde, 2001, Jul-28, Volume: 145, Issue:30 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cost-Benefit Analysis; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Gastritis; Humans; Lactones; Meloxicam; Netherlands; Pyrazoles; Sulfonamides; Sulfones; Thiazines; Thiazoles	2001
Characterization of the effects of antiangiogenic agents on tumor pathophysiology. American journal of clinical oncology, 2001, Volume: 24, Issue:5 Topics: Angiogenesis Inhibitors; Animals; Celecoxib; Cell Hypoxia; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Etanidazole; Hydrocarbons, Fluorinated; Image Processing, Computer-Assisted; Immunohistochemistry; Isoenzymes; Mammary Neoplasms, Experimental; Meloxicam; Mice; Mice, Inbred C3H; Models, Animal; Neovascularization, Pathologic; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Thiazines; Thiazoles	2001
Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut, 2001, Volume: 49, Issue:5 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chromatography, High Pressure Liquid; Confidence Intervals; Cyclooxygenase Inhibitors; Delayed-Action Preparations; Female; Gastric Mucosa; Humans; Indomethacin; Intestinal Mucosa; Lactulose; Male; Mannitol; Meloxicam; Middle Aged; Naproxen; Permeability; Pyrazoles; Statistics, Nonparametric; Sucrose; Sulfonamides; Thiazines; Thiazoles	2001
New cyclooxygenase-2 inhibitors for treatment of experimental autoimmune neuritis. Muscle & nerve, 2002, Volume: 25, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Indomethacin; Isoenzymes; Male; Meloxicam; Neuritis, Autoimmune, Experimental; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Inbred Lew; Sciatic Nerve; Sulfonamides; Thiazines; Thiazoles	2002
Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:4 Pt 1 Topics: Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Carcinoma, Hepatocellular; Carrier Proteins; Caspases; Celecoxib; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Liver Neoplasms; Meloxicam; Membrane Proteins; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Sulfonamides; Thiazines; Thiazoles; Tumor Cells, Cultured	2002
Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data. Rheumatology (Oxford, England), 2003, Volume: 42, Issue:11 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Cohort Studies; Cyclooxygenase Inhibitors; England; Family Practice; Female; Gastrointestinal Diseases; Humans; Incidence; Male; Meloxicam; Middle Aged; Osteoarthritis; Poisson Distribution; Pyrazoles; Regression Analysis; Retrospective Studies; Risk Factors; Sulfonamides; Thiazines; Thiazoles	2003
Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data. Rheumatology (Oxford, England), 2003, Volume: 42, Issue:11 Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Celecoxib; Cerebrovascular Disorders; Chi-Square Distribution; Cohort Studies; Cyclooxygenase Inhibitors; England; Family Practice; Female; Humans; Incidence; Male; Meloxicam; Middle Aged; Osteoarthritis; Peripheral Vascular Diseases; Pyrazoles; Risk Factors; Sulfonamides; Survival Analysis; Thiazines; Thiazoles; Thromboembolism	2003
Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. Gut, 2003, Volume: 52, Issue:9 Topics: Anti-Inflammatory Agents, Non-Steroidal; Bias; Celecoxib; Cohort Studies; Databases, Factual; Family Practice; Female; Gastrointestinal Hemorrhage; Humans; Lactones; Male; Meloxicam; Middle Aged; Pyrazoles; Risk Factors; Sulfonamides; Sulfones; Thiazines; Thiazoles	2003
Solubility enhancement of Cox-2 inhibitors using various solvent systems. AAPS PharmSciTech, 2003, Volume: 4, Issue:3 Topics: Celecoxib; Chemistry, Pharmaceutical; Cyclooxygenase 2; Enzyme Inhibitors; Hydrogen-Ion Concentration; Isoenzymes; Lactones; Meloxicam; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Solubility; Solvents; Sulfonamides; Sulfones; Thiazines; Thiazoles	2003
Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats. British journal of pharmacology, 2004, Volume: 141, Issue:7 Topics: Animals; Arachidonic Acids; Atenolol; Behavior, Animal; Biogenic Amines; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Captopril; Celecoxib; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Facial Pain; Formaldehyde; Guanethidine; Hindlimb; Indomethacin; Injections, Subcutaneous; Interleukin-6; Interleukin-8; Lip; Male; Meloxicam; Nociceptors; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Sulfonamides; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha; Tyramine	2004
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs. Atherosclerosis, 2004, Volume: 177, Issue:2 Topics: Animals; Antioxidants; Celecoxib; Cholesterol, LDL; Chromans; Cyclooxygenase Inhibitors; Diclofenac; Humans; Ibuprofen; Isoprostanes; Isoxazoles; Lactones; Meloxicam; Naproxen; Oxidation-Reduction; Pyrazoles; Sulfonamides; Sulfones; Thiazines; Thiazoles	2004
Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006, Volume: 20, Issue:3 Topics: Aspirin; Blood Platelets; Blood Proteins; Calcimycin; Calcium; Celecoxib; Cell Line; Cerebrospinal Fluid Proteins; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Humans; Indomethacin; Ionophores; Lactones; Meloxicam; Naproxen; Organ Specificity; Organic Chemicals; Protein Binding; Pyrazoles; Sodium Salicylate; Sulfonamides; Sulfones; Synovial Fluid; Thiazines; Thiazoles; Thromboxane A2	2006
Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study. Drug safety, 2006, Volume: 29, Issue:3 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Databases, Factual; Female; Humans; Insurance, Pharmaceutical Services; Ischemic Attack, Transient; Lactones; Male; Meloxicam; Middle Aged; Myocardial Infarction; National Health Programs; Proportional Hazards Models; Pyrazoles; Risk Assessment; Stroke; Sulfonamides; Sulfones; Taiwan; Thiazines; Thiazoles; Time Factors	2006
Simultaneous determination of celecoxib, meloxicam, and rofecoxib using capillary electrophoresis with surfactant and application in drug formulations. Journal of separation science, 2006, Volume: 29, Issue:7 Topics: Celecoxib; Chemistry, Pharmaceutical; Cyclooxygenase 2 Inhibitors; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Lactones; Meloxicam; Molecular Structure; Pyrazoles; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Sulfones; Surface-Active Agents; Thiazines; Thiazoles	2006
[Effects of selective and non-selective cyclooxygenase-2 inhibitor on the growth of colon cancer cells]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2006, Volume: 37, Issue:4 Topics: Apoptosis; Aspirin; Celecoxib; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Humans; Meloxicam; Pyrazoles; Sulfonamides; Thiazines; Thiazoles	2006
Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependent. Clinical and experimental pharmacology & physiology, 2006, Volume: 33, Issue:10 Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Celecoxib; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Kidney; Lactones; Male; Meloxicam; Placebos; Potassium; Pyrazoles; Rats; Rats, Sprague-Dawley; Sodium; Sulfonamides; Sulfones; Thiazines; Thiazoles	2006
Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol. Digestive diseases and sciences, 2007, Volume: 52, Issue:2 Topics: Animals; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cytoprotection; Diclofenac; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Gastric Acid; Gastric Mucosa; Ibuprofen; Irritants; Male; Meloxicam; Membrane Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyrazoles; Rats; Rats, Wistar; Stomach Ulcer; Sulfonamides; Thiazines; Thiazoles	2007
Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration. International journal of radiation biology, 2007, Volume: 83, Issue:10 Topics: Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Radiation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioma; Humans; Meloxicam; Neoplasms; Nitrobenzenes; Pyrazoles; Radiation-Protective Agents; Sulfonamides; Thiazines; Thiazoles	2007
[Induction of NAG-1 gene expression in colon cancer cells by non-steroidal anti-inflammatory drugs]. Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2007, Volume: 24, Issue:4 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Celecoxib; Cell Proliferation; Cyclooxygenase 2; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Meloxicam; Neoplasm Proteins; Pyrazoles; RNA, Messenger; Sulfonamides; Thiazines; Thiazoles	2007
Effects of non-steroidal anti-inflammatory drugs on proliferation, differentiation and migration in equine mesenchymal stem cells. Cell biology international, 2011, Volume: 35, Issue:3 Topics: Aggrecans; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Celecoxib; Cell Differentiation; Cell Movement; Cell Proliferation; Clonixin; Collagen Type II; Core Binding Factor Alpha 1 Subunit; Female; Horses; Male; Meloxicam; Mesenchymal Stem Cells; Phenylbutazone; Pyrazoles; Sulfonamides; Thiazines; Thiazoles	2011
Safe administration of celecoxib to a patient with repeated episodes of nephrotic syndrome induced by NSAIDs. Clinical drug investigation, 2011, Volume: 31, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Humans; Male; Meloxicam; Middle Aged; Nephrotic Syndrome; Osteoarthritis, Hip; Pyrazoles; Recurrence; Remission Induction; Sulfonamides; Thiazines; Thiazoles	2011
Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats. Life sciences, 2011, Apr-25, Volume: 88, Issue:17-18 Topics: Animals; Brain; Caspase 3; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Huntington Disease; Inflammation; Interleukin-6; Lipid Peroxidation; Locomotion; Male; Meloxicam; Mitochondria; Oxidative Stress; Pyrazoles; Quinolinic Acid; Rats; Rats, Wistar; Sulfonamides; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha	2011
Management of acute calcific tendinitis around the hip joint. The American journal of sports medicine, 2014, Volume: 42, Issue:11 Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Arthroscopy; Calcinosis; Calcium Phosphates; Celecoxib; Female; Follow-Up Studies; Hip Joint; Humans; Injections, Intra-Articular; Male; Meloxicam; Middle Aged; Musculoskeletal Pain; Pain Measurement; Pyrazoles; Radiography; Retrospective Studies; Steroids; Sulfonamides; Tendinopathy; Thiazines; Thiazoles; Tramadol	2014
Actions following adverse drug events - how do these influence uptake and utilisation of newer and/or similar medications? BMC health services research, 2015, Nov-06, Volume: 15 Topics: Aged; Australia; Bone Density Conservation Agents; Celecoxib; Cyclooxygenase 2 Inhibitors; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lactones; Medication Adherence; Meloxicam; Osteoporosis; Sulfones; Thiazines; Thiazoles	2015
[Cognitive-cytokine effect of nonsteroidal antiinflammatory drugs in the therapy of elderly patients with osteoarthritis]. Advances in gerontology = Uspekhi gerontologii, 2017, Volume: 30, Issue:3 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cognition; Cognition Disorders; Cytokines; Etoricoxib; Female; Humans; Interleukin-1beta; Interleukin-6; Male; Meloxicam; Osteoarthritis; Prospective Studies; Pyridines; Sulfonamides; Sulfones; Thiazines; Thiazoles; Transforming Growth Factor beta1	2017
Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis. Diagnostic pathology, 2017, Aug-29, Volume: 12, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta Catenin; Celecoxib; Cell Nucleus; Child; Cyclooxygenase 2 Inhibitors; Female; Fibromatosis, Aggressive; Humans; Immunochemistry; Male; Meloxicam; Middle Aged; Mutation; Prognosis; Staining and Labeling; Thiazines; Thiazoles; Young Adult	2017
Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus). Scientific reports, 2017, 09-25, Volume: 7, Issue:1 Topics: Administration, Oral; Animals; Celecoxib; Cockatoos; Cyclooxygenase 2 Inhibitors; Meloxicam; Pyrazoles	2017
Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid. Journal of pharmaceutical sciences, 2018, Volume: 107, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arthritis, Experimental; Celecoxib; Cytochrome P-450 Enzyme System; Heart; Hydroxyeicosatetraenoic Acids; Inflammation; Kidney; Lactones; Male; Meloxicam; Rats; Rats, Sprague-Dawley; Sulfones; Thiazines; Thiazoles	2018
Effect on Risk of Stroke and Acute Myocardial Infarction of Nonselective Nonsteroidal Anti-Inflammatory Drugs in Patients With Rheumatoid Arthritis. The American journal of cardiology, 2018, 05-15, Volume: 121, Issue:10 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Diclofenac; Female; Humans; Ibuprofen; Logistic Models; Male; Mefenamic Acid; Meloxicam; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Factors; Stroke	2018
Meloxicam versus Celecoxib for Postoperative Analgesia after Total Knee Arthroplasty: Safety, Efficacy and Cost. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2022, 04-05, Volume: 6, Issue:4 Topics: Analgesia; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Knee; Celecoxib; Cyclooxygenase 2 Inhibitors; Humans; Meloxicam	2022
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials. Drug safety, 2022, Volume: 45, Issue:9 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 2 Inhibitors; Diclofenac; Etodolac; Etoricoxib; Female; Heart Disease Risk Factors; Humans; Meloxicam; Risk Factors	2022
[Evaluation of the effectiveness of treatment of patients with nonspecific pain syndrome in the lower back with celecoxib and a combined preparation of B vitamins]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2022, Volume: 122, Issue:8 Topics: Adult; Celecoxib; Chronic Pain; Female; Humans; Low Back Pain; Male; Meloxicam; Middle Aged; Pain Measurement; Vitamin B Complex	2022
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study. Tuberkuloz ve toraks, 2022, Volume: 70, Issue:4 Topics: Acetaminophen; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Hypersensitivity; Female; Humans; Male; Meloxicam; Middle Aged; Respiratory Hypersensitivity; Respiratory Tract Diseases; Retrospective Studies	2022

chemdatabank.com